Glenmede Trust’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-848
Closed -$41K 1625
2020
Q3
$41K Buy
848
+17
+2% +$747 ﹤0.01% 1380
2020
Q2
$31K Buy
831
+587
+241% +$21.9K ﹤0.01% 1439
2020
Q1
$13K Hold
244
﹤0.01% 2303
2019
Q4
$13K Hold
244
﹤0.01% 2303
2019
Q3
$15K Hold
244
﹤0.01% 2176
2019
Q2
$18K Hold
244
﹤0.01% 2103
2019
Q1
$19K Buy
244
+19
+8% +$1.27K ﹤0.01% 2087
2018
Q4
$12K Buy
+225
New +$13.5K ﹤0.01% 2200
2018
Q2
Sell
-680
Closed -$17K 2061
2018
Q1
$17K Hold
680
﹤0.01% 2020
2017
Q4
$17K Sell
680
-7,419
-92% -$221K ﹤0.01% 2020
2017
Q3
$266K Sell
8,099
-7,581
-48% -$288K ﹤0.01% 1120
2017
Q2
$803K Hold
15,680
﹤0.01% 818
2017
Q1
$803K Buy
15,680
+680
+5% +$29.6K ﹤0.01% 818
2016
Q4
$514K Buy
+15,000
New +$513K ﹤0.01% 935

Other funds holding GKOS

Glenmede Trust's GKOS Position: Q4 2020 in Review

Glenmede Trust sold out of Glaukos (GKOS) in Q4 2020, closing a stake of 848 shares — an estimated $41K sold.

Glenmede Trust first reported a position in GKOS in Q4 2016 and held it in 14 quarters. The position peaked at $803K in Q2 2017. 208 funds tracked by Wall St. Rank hold GKOS as of Q4 2020.

  • Glenmede Trust reported no remaining Glaukos position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 848 Glaukos shares in Q4 2020, an estimated $41K.
  • Glenmede Trust first reported a position in Glaukos in Q4 2016 and held it in 14 quarters.
  • Glenmede Trust's Glaukos position peaked at $803K in Q2 2017.
  • 208 funds tracked by Wall St. Rank held Glaukos as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.